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Although, the precise molecular mechanisms underlying Parkinson’s disease (PD)
are still elusive, it is now known that spreading of alpha-synuclein (aSyn) pathology
and neuroinflammation are important players in disease progression. Here, we developed
a novel microfluidic cell-culture platform for studying the communication between two
different cell populations, a process of critical importance not only in PD but also in
many biological processes. The integration of micro-valves in the device enabled us to
control fluid routing, cellular microenvironments, and to simulate paracrine signaling. As
proof of concept, two sets of experiments were designed to show how this platform
can be used to investigate specific molecular mechanisms associated with PD. In one
experiment, naïve H4 neuroglioma cells were co-cultured with cells expressing aSyn
tagged with GFP (aSyn-GFP), to study the release and spreading of the protein. In our
experimental set up, we induced the release of the contents of aSyn-GFP producing
cells to the medium and monitored the protein’s diffusion. In another experiment, H4 cells
were co-cultured with N9 microglial cells to assess the interplay between two cell lines in
response to environmental stimuli. Here, we observed an increase in the levels of reactive
oxygen species in H4 cells cultured in the presence of activated N9 cells, confirming the
cross talk between different cell populations. In summary, the platform developed in this
study affords novel opportunities for the study of the molecular mechanisms involved in
PD and other neurodegenerative diseases.
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative
disorder characterized both by the loss of dopaminergic neurons
in the substantia nigra pars compacta and the accumulation
of intracellular protein inclusions primarily made up of alpha-
synuclein (aSyn), known as Lewy bodies (Spillantini et al., 1997;
Baba et al., 1998; Dauer and Przedborski, 2003; Goedert et al.,
2012). Although, the precise molecular mechanisms underlying
PD are still elusive (Obeso et al., 2010), sustained microglia
activation and neuroinflammation seem to also contribute to the
disease (Kim and de Vellis, 2005; Block et al., 2007; Long-Smith
et al., 2009; Whitton, 2009; Glass et al., 2010). Several studies
have suggested that aSyn aggregation and microglia activation
might be connected, resulting in chronic neuroinflammation
(Streit et al., 1999; Zhang et al., 2005; Su et al., 2008). Since
it is known that aSyn is released and taken up by neighboring
cells, thereby contributing to the progression of the disease
(Lee et al., 2008), and that microglia sustains inflammation and
damages surrounding cells mainly by releasing molecules such as
cytokines and reactive oxygen species (ROS; Block et al., 2007),
it would be important to investigate the interplay between these
two processes using a platform that would enable the exchange
of soluble molecules between different cell types. Such a platform
would have to be able to replicate in vivo events where paracrine
signaling is mostly dependent on diffusion and, at the same time,
allow to quickly change the cellular microenvironment to provide
cells with physical and/or chemical stimuli.
The use of cell models and traditional cell culture techniques
enabled the isolation and replication of in vivo events to study
both diseases and normal physiological processes. However,
macroscopic cell culture techniques struggle to replicate events in
which paracrine communication between different types of cells
is key: tight spatial control over the cellular microenvironment
and chemical stimuli are hard to achieve, the coexistence of
diffusion, and convection make communication control and
monitoring difficult, and when volumes are in the mL range
the factors secreted by cells become diluted and ineffective.
Microfluidic systems excel in the control and handling of both
fluids and microenvironments (Toh et al., 2010; Young and
Beebe, 2010; Mehling and Tay, 2014), due to the size scale,
laminar fluid flow (Beebe et al., 2002), and the ability to pattern
and modify the substrate where cells adhere (Kane et al., 1999;
Rhee et al., 2005). Furthermore, microfluidic platforms equipped
with integrated valves allow additional control, not only by
permitting better fluid routing but also by offering the ability
to keep defined sections of the platform isolated from other
sections (Unger et al., 2000; Thorsen et al., 2002). This type
of control makes microfluidics an excellent tool to study cell-
cell communication by soluble factors, bridging the gap between
in vitro and in vivo.
The advantages presented by microfluidic for cell culture
are particularly useful for neurosciences and, as such, new
platforms have been widely reported (Wang et al., 2009; Taylor
and Jeon, 2010; Park et al., 2013). Some of these platforms
present new solutions for very specific issues, from the study
of axonal injury (Taylor et al., 2005) to the propagation of
action potentials along axons (Dworak and Wheeler, 2009).
The study of neurodegenerative diseases such as PD, in which
paracrine signaling plays an important role, requires a platform
that allows the co-culturing of different cell lines. Microfluidic
devices designed for cell culture have been previously extensively
reported (El-Ali et al., 2006; Mehling and Tay, 2014) but are
usually either too complex for studying two cell populations or
lack one or more desired features for this type of study. One
platform has been reported that studies the interaction between
microglia and neuroblastoma (Lovchik et al., 2009), but uses
perfusion to ensure communication between the two populations
of cells, not allowing to replicate diffusion-based events. Other
recent platforms allow the study of diffusion-based events
(Majumdar et al., 2011; Shi et al., 2013), but either do not ensure
that cells are kept physically separated throughout the duration
of the experiment—allowing for other types of communication
such as juxtacrine signaling—or cannot manipulate the chemical
environment of each cell population separately, the stimulation
or specific activation of a given population for more complex
studies. A device used to mimic the human gastrointestinal
tract (Ramadan et al., 2013) allows the studying of the
interaction between two co-cultured cell populations and the
selective stimulation of each one, but since one population is
cultured on top of a porous membrane true microenvironment
separation cannot be achieved. Finally, a platform designed
specifically for studying paracrine signaling by diffusion has
been recently reported (Byrne et al., 2014), it relies on cell
populations trapped in a 3D gel matrix, thereby complicating the
dynamic manipulation of the microenvironment by perfusion.
Although, all of these platforms successfully tackle their target
application, to our knowledge no device is currently available
that allows to study paracrine communication between physically
separated cells all the while offering the possibility of dynamic
and individual population stimulation and the keep isolated
microenvironments for a user-defined amount of time.
In this study, we developed a novel microfluidic platform to
study the communication between two different cell populations
via soluble molecules. The platform is built around two cell
culture chambers connected by three channels and equipped with
integrated pneumatic valves that allow the cell populations to
either be isolated from each other, or to be in communication
via the exchange of soluble molecules and factors. The device
is also designed in such a way that this communication can be
established either by diffusion or by perfusion. In fact, since the
distance between the two chambers is 250µm,molecules released
by one cell population can rapidly diffuse to the other, thereby
mimicking in vivo conditions where cells are close together and
paracrine signaling is efficient (Young and Beebe, 2010). Since
the volumes used are in the nL range and the chambers are kept
isolated from the rest of the platform, molecules remain confined
in the cell culture area and do not diffuse to other areas of the
device. Furthermore, since the device is made with transparent
polydimethylsiloxane (PDMS), a versatile material that has been
extensively used in biological and cell culture applications (Quake
and Scherer, 2000; McDonald and Whitesides, 2002; Makamba
et al., 2003; Sia and Whitesides, 2003; Mata et al., 2005; Berthier
et al., 2012; Hegab et al., 2013; Xu et al., 2015), the platform is
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ideally suited for microscopy-based applications that afford the
possibility of obtaining sub-cellular resolution in real-time and
in living cells.
To demonstrate the usefulness of this platform and the
relevance of monitoring cell-cell communication, we exploited
molecular mechanisms associated with PD to conduct two
proof-of-concept experiments: the study of the transmission of
aSyn between two cell populations; and the impact of activated
microglia cells on a neuron-like cell population. Although, co-
cultures of neuron andmicroglia have been previously conducted
(Lovchik et al., 2009; Majumdar et al., 2011; Shi et al., 2013), this
new platform allows cells to communicate either by diffusion or
by perfusion of molecules from one chamber to the other, while
avoiding direct cell-cell contact throughout the duration of the
experiments. In summary, this platform provides an important
tool for replicating conditions closer to in vivo, while keeping
a very tight control over the cells’ microenvironment and their
form of communication, and tracking their behavior in real
time. The experimental venues made possible by this platform
now enable future studies, namely focused on cell-cell interplay,
that are extremely hard to achieve using current macroscopic
technology.
MATERIALS AND METHODS
Device Design and Operation
The microfluidic platform comprises two 600 × 900 × 70
µm chambers, each with a volume of 36 nL, linked by three
250 µm long, 125 µm wide channels (Figure 1). Three inlets
are connected to a common channel that is connected to
both chambers and ends in a common flush outlet. One inlet
is dedicated to medium and the other two to different cell
populations, thus avoiding cross-contamination. Each chamber
also has a dedicated, independent outlet.
Integrated pneumatic valves composed of 150 µm wide
channels allow the routing of medium and cells to each chamber
independently, the isolation of the microenvironment of each
chamber, and the blocking of each inlet to the common channel
(Figure 2). The channels between the chambers are also equipped
with an integrated valve.
Before inserting cells, each device was sterilized and primed.
Ethanol 70% was inserted into the microfluidic chip with a
syringe pump (New Era Pump Systems, NY, USA) after which
all inlets except one were plugged with a steel plug. Pressured
air was then applied in the unplugged inlet at 80 kPa for 5 min
to release all existing air bubbles (Kim et al., 2007). The channels
were then rinsed with phosphate buffered saline (PBS) and coated
with fibronectin (FN) to improve cell adhesion and proliferation
(Klebe et al., 1981; Lee et al., 2004). The coating was performed
by flowing a solution of 50 µg/mL of FN in PBS and incubating
for at least 1 h at 37◦C. Finally, before seeding the cells in the cell
chambers, the device was rinsed with cell culture medium.
The pneumatic channels were also filled with DI water
by filling the capillary tubing and applying about 200 kPa
of pressure. By filling the channels with water one is able
to effectively actuate the valves without running the risk of
generating air bubbles in the medium by diffusion of gas through
the PDMS membrane (Studer et al., 2004). The effectiveness of
this type of valves was shown previously (Unger et al., 2000;
Thorsen et al., 2002; Araci and Quake, 2012), and its leak-proof
character was further verified with experiments using air bubbles
and fluorescein isothiocyanate (data not shown).
Activation of the valves was controlled by switches
connected to a simple custom-made printed circuit board
(PCB; Supplementary Figure 1). The PCB was connected to a 24
V power source and the switches control small solenoid valves
(SY144-5MZ-Q, SMC Corporation, Tokyo, Japan) mounted on
a manifold, itself connected to a regulator and a pressured-air
line. Each solenoid valve was linked to an integrated valve by
polyethylene tubing (Instech Laboratories Inc., PA, USA).
Fabrication
Mold
Two molds were required to build the microfluidic device: one
for the fluidic layer, and a second for the pneumatic or control
layer. Two different photoresists were used in the fabrication
of the mold for the fluidic layer: SU-8 50 (MicroChem Corp.,
Newton, MA, USA) and AZ40 XT (MicroChemicals GmbH,
Ulm, Germany), which are negative and positive photoresists
respectively. This allowed to fabricate chambers and inlet
punching marks with well-defined vertical walls using the
negative photoresist and fluidic channels with a rounded cross-
section, essential for the efficient operation of deflection-based
pneumatic valves (Unger et al., 2000; Studer et al., 2004), by
reflowing the positive photoresist. A 75 × 75 mm Si substrate
was rinsed with de- ionized water (DI water), acetone and IPA
and treated with 20 min of UV (UVO-Cleaner R© 144AX, Jelight
Company Inc., Irvine, CA, USA) to improve the substrate’s
wettability to SU-8 and prevent the regression and accumulation
of the film toward the center of the substrate. SU-8 50 was spin
coated at a final speed of 1500 rpm for 30 s, resulting in a final film
thickness of about 70 µm. The film was processed according to
the specifications of the manufacturer’s datasheet, hard baked for
1 h at 180◦C and left to cool down on the hot plate. This produced
the cell chambers and punching marks for inlets and outlets.
AZ40 XT was then dispensed on top of the Si substrate with the
SU-8 features and left to settle for 4 min before spin coating at a
final speed of 2000 rpm for 21 s and left again to settle for 30 min.
These settling times are essential since the photoresist is viscous
and tends to trap air bubbles between existing SU-8 features on
the substrate, which are spread throughout the substrate during
spin-coating. Soft-bake consisted of ramping the temperature
from 100 to 125◦C and baking for 5 min, followed by a 3 min
cool down. A post-exposure bake at 105◦C was performed for
2 min and the film was developed in AZ 400 K, a KOH-based
developer. To obtain the required round cross-section, the AZ40
XT photoresist was reflowed in four steps: 5 min at 80◦C, 5
min at 100◦C, 15 min at 115◦C, and 5 min at 125◦C, with
temperature ramping while the substrate was on the hotplate.
After this treatment, channels with a rounded cross-section and
a maximum height of 35 µm were obtained.
The pneumatic mold was fabricated with SU-8 2015: the
substrate was first coated with a uniform layer of SU-8 2015
to facilitate PDMS release and the 20 µm features were
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FIGURE 1 | Device overview. Image of the microfluidic platform made by stitching several transmitted light microscopy images. The device includes 3 inlets, one
main channel served by an outlet and two cell culture chambers with dedicated outlets. The cell culture chambers are connected to each other by three channels.
Integrated pneumatic valves (dashed red lines) in a different PDMS layer allow to control fluid flow and to isolate inlets and cameras. A given cell culture chamber can
be isolated by activating the valves at the entrance and exit, and the valve serving the central channels. Top right: schematic detail of the microfluidic structure with the
cell culture chambers (green), pneumatic channels (red), and channels with a round cross-section (blue). For the mold of the flow layer, culture chambers, inlets and
outlets were patterned with SU-8, while the channels with a round-cross section were patterned with AZ 40XT.
FIGURE 2 | Schematic of the flow control mechanism of the device. Valves can be activated independently to route fluid to the left chamber (A) or the right
chamber (B). Individual chambers can be isolated from the rest of the platform (C) or both of them can be isolated while allowing diffusion between them (D). Valves
are shown in red, channels in blue, and cell culture chambers in green. The direction of the fluid flow is given by the white arrow.
patterned on a second layer according to the specifications of the
manufacturer’s datasheet.
Device
The device was fabricated with two PDMS layers (Sylgard
184, Dow Corning, Midland, MI) to allow the integration of
pneumatic valves (Figure 1). The fluidic mold was placed into
a poly(methyl methacrylate) (PMMA) case with a 5 mm thick
spacer and a drilled lid. The several parts of the case were held
together with metallic clips. Metallic connectors with a 23 ga
diameter were inserted through the drills in the lid and aligned
with the punching marks to form the access channels. PDMS
at a 1:10 ratio was then inserted with a syringe through a hole
placed on a corner of the lid until it filled the whole space and
flowed out through another hole on the opposite corner. The bulk
PDMS was then cured for 50 min at 70◦C, after which the PDMS
was released from the mold and the metallic connectors pushed
through the bulk until they emerged on the other side ensuring
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that they went across the entire thickness of the PDMS. PDMS
at a 1:20 ratio was spin-coated at 2200 rpm to obtain a thickness
of about 30 µm on top of the pneumatic mold and cured for 40
min at 70◦C. After curing, a small drop of ethanol was put on
top of the 1:20 PDMS to serve as a lubricating layer to allow the
alignment of both layers. It should be noted that, due to PDMS
shrinkage (Lee and Lee, 2007; Moraes et al., 2009) the features
of the mold for the bulk PDMS were scaled up by a factor of
1.012. After alignment the device was further cured for at least
1 h 30 min at 70◦C and the access ports to the pneumatic layer
were punched with a 20 ga luer stub. The device was then sealed
against a glass coverslip (Hirschmann Laborgeräte GmbH & Co.,
Eberstadt, Germany) using oxygen-plasma bonding: both the
device and the coverslip were exposed to oxygen-plasma (Harrick
Plasma, Ithaca, NY, USA) for about 60 s, then brought into
contact, creating a strong, irreversible bond (McDonald et al.,
2000; Eddings et al., 2008). Finally, 22 ga right-angle stainless
steel couplers (Instech Laboratories Inc., PA, USA) were inserted
into the inlets and outlets and a drop of PDMS was applied to
the interface of these ports with a syringe to create a liquid-proof
sealing after curing for at least 30min at 70◦C.
Cell Culture Conditions and Transfections
Human H4 neuroglioma cells (HTB-148, LGC Standards,
Barcelona, Spain) were cultured in Opti-MEM (Gibco, Thermo
Fisher Scientific Inc, Waltham, MA, USA), supplemented
with 10% heat inactivated fetal bovine serum (FBS, reference
10500-064, lot 07Q2330K, Gibco, Thermo Fisher Scientific Inc,
Waltham,MA, USA) and 1% penicillin-streptomycin (pen-strep)
and maintained at 37◦C and 5% CO2. Before transfection, cells
were plated in T-25 flasks and allowed to reach 70% confluence.
Cells were transfected with wild type aSyn tagged with GFP
(αSyn-WT-EGFP, WTSynEGFP plasmid previously described;
McLean et al., 2001) or GFP (EGFP, pEGFP-N3 plasmid;
Clontech, Palo Alto, CA, USA) using FuGENE (Promega
Corporation, Wisconsin, USA). To select stably transfected
populations, the mediumwas replaced with Opti-MEM complete
medium supplemented with 400 µg/mL of G418 (Thermo Fisher
Scientific Inc, Waltham, MA, USA) 24 h after transfection.
A control flask containing non-transfected H4 cells was used
to assess the efficacy of the selection. After the selection was
completed, transfected cells were maintained in Opti-MEM
complete medium supplemented with 200 µg/mL of G418.
N9 cells (a kind gift fromDr. Paula Ricciardi-Castagnoli) were
cultured in RPMI 1640 (Gibco, Thermo Fisher Scientific Inc,
Waltham, MA, USA) supplemented with 10% heat-inactivated
FBS and 1% pen-strep. Activation of N9 cells was achieved
by replacing the medium with RPMI 1640 complete medium
supplemented with 1 µg/mL of lipopolysaccharides (LPS, from
Escherichia coli 055:B5, chromatographically purified by gel
filtration, Sigma-Aldrich, St. Louis, MO, USA) and incubating for
at least 12 h.
Image Acquisition and Processing
All images were acquired with a Nikon Eclipse Ti-E inverted
microscope (Nikon Corporation, Tokyo, Japan) equipped with
a motorized stage, a cage incubator for temperature control
and a stage-top gas chamber for CO2 control (Okolab S.R.L.,
Pozzuoli, NA, Italy). Transmitted light and fluorescent images
were acquired with a dry 10 × Nikon CFI Plan Fluor objective
with a numerical aperture of 0.30 and a high sensitivity
Andor iXon Ultra 897 EMCCD camera (Oxford Instruments,
Oxfordshire, UK).
Acquired images were analyzed using ImageJ software (NIH,
Bethesda, MD, USA) and stitched using the pairwise stitching
plugin (Preibisch et al., 2009).
H4 Cell Seeding and aSyn-GFP Release
Cells in suspension were loaded in a syringe and inserted into the
device at one of the inlets and a controlled flow was maintained
by a syringe pump; liquid was allowed to flow through the
common channel to the flush outlet until cells were seen entering
the inlet; valves routed the cells into the chamber and the valve
at the entrance of the chamber was opened and closed until the
appropriate number of cells was inside the chamber. Since inertia
does not play a significant role in this flow regime, the fluid flow
stops immediately once the valve is closed and the number of
cells can be quickly assessed. Cells were then allowed to sediment
and adhere to the substrate for at least 90 min: it was seen that
this was the necessary time for cells to spread on the substrate
and acquire their typical epithelial-like morphology. It should
be noted that several seeding rounds are possible: since cells are
quick to sediment and adhere to the substrate in a few minutes,
new cells in suspension can be routed into the chamber without
detaching the previously seeded ones. Throughout the seeding
process the channels linking both chambers were kept closed
to prevent cross-contamination, and after the seeding of each
cell population the common channel was rinsed with medium
at a high flow rate (above 20 µL/min). Since during seeding the
suspended cells are in constant perfusion through the common
channel, and we can seamlessly switch the incoming flow from
the cell to the medium inlets, cells do not have the chance to
sediment and adhere to this channel, further minimizing the
chance for cross-contamination.
After the static adhesion time, medium inside each chamber
was renewed by flowing medium at 5 µL/min for 10–20 s—
which was also used to flush non-adhered or dead cells. Two
hours after insertion cells were already expressing aSyn-GFP, as
evidenced by a strong fluorescence signal. At this time point, a
solution of Triton X-100 (Panreac Química S.L.U., Barcelona,
Spain) 0.05% in PBS was perfused for about 5 s at 5 µL/min in
the cell chamber containing the cells with aSyn-GFP, after which
the chamber was isolated by closing the valves at the entrance
and exit. The cells were kept isolated for 20 min, after which the
central channels were opened. This concentration of Triton was
optimized so that it is sufficient to permeabilize themembranes of
the cells inside the chamber, releasing aSyn-GFP in the medium,
without affecting cells in the neighboring chamber once the valve
is opened (Figure 3).
After the central channel was opened, aSyn-GFP diffused to
the neighboring chamber (Figure 4). Both cell chambers were
kept isolated but with the central channels open for 10 h, after
which they were rinsed with PBS, fluorescent images were taken
and a viability staining was performed. For the staining 10µg/mL
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FIGURE 3 | Release of aSyn-GFP by treatment with Triton X-100. (A)
Cells producing aSyn-GFP (left) are permeabilized with 0.05% Triton X-100 in
PBS and start releasing their contents to the medium in a matter of seconds
(right). (B) Transmission microscopy images show that cells treated with Triton
X-100 suffer significant morphological changes (left) and that 10 h after
opening the central channel the wild type H4 cells are unaffected by Triton
X-100 (right). This was also confirmed by viability staining with PI.
Fluorescence images acquired with a 300ms exposure.
of propidium iodide (PI) was introduced in the device and left to
incubate for about 20 min.
N9 and H4 Co-culture
For N9 and H4 co-culture, two sets of experiments were made:
one with activated, and another with non-activated N9 cells.
Seeding of both N9 and H4 was made as described above. In
the assay with LPS-activated N9, previously activated cells were
suspended in RPMI 1640 complete medium supplemented with 1
µg/mL LPS, while non-activated N9 were suspended in complete
medium without LPS prior to seeding. Cells were left to settle
and adhere for 2 h, after which medium was changed for both
populations. In both sets of experiments, the fresh medium did
not contain LPS. The central channel was opened 30 min after
the medium change, and diffusion was allowed to occur for 10 h.
At the end of the time allowed for diffusion, DHE at 30 µM in
Opti-MEM complete medium was inserted in the chambers and
left to incubate for 20 min at 37◦C.
RESULTS AND DISCUSSION
aSyn Spreading
The prion-like spreading of aSyn pathology in the brains of PD
patients is intriguing, and the precise molecular mechanisms
involved are still elusive (Li et al., 2008; Olanow and Prusiner,
2009). Here, we took advantage of the microfluidic platform
we developed to study and monitor the transfer of this protein
between two cell populations in real time. By co-culturing
cell populations expressing or not expressing aSyn, we studied
conditions that affected the release and uptake of the protein. For
this purpose, we used a GFP-tagged version of aSyn (aSyn-GFP;
previously described in McLean et al., 2001), to enable the
imaging of the process in living cells and in real-time. In this
particular proof-of-concept study we focused on the uptake
of aSyn and, therefore, promoted the release of aSyn-GFP by
permeabilizing the cell membrane.
To study the spreading of aSyn between cells (Lee et al.,
2008; Lashuel et al., 2012) naïve H4 cells were cultured with H4
cells expressing aSyn-GFP in the two chambers of the device as
described above. This cell line chosen since H4 cells and other
types of neuroblastoma have been extensively used in the study
of the release of aSyn and other proteins (El-Agnaf et al., 2003;
Alvarez-Erviti et al., 2011; Herrera et al., 2011; Chutna et al.,
2014).
To assess if the uptake of aSyn-GFP occurred, the fluorescence
signal of naïve H4 cells was measured before the opening of
the central valve and after a 10 h exposure to aSyn-GFP in
solution followed by washing with PBS. Regions of interest
(ROIs) corresponding to the cells’ perimeter were defined using
a transmitted light microscopy image and these were used to
measure the signal intensity in the fluorescence microscopy
image. To ensure that the ROIs captured the fluorescence signal
of the entire cells, transmitted light and fluorescence images were
captured at the same time point. Cells that stained positive for PI
were discarded from this selection. Since other studies reported
spreading of aSyn between cells in as little as 5 min (Lee et al.,
2008), we surmised that 10 h was an appropriate time frame to
observe uptake events.
Since cells change shape and divide throughout the duration of
the experiment, it was not practical to track each single cell and
evaluate the change in fluorescence signal. The method used to
determine if aSyn-GFP entered the cells, either through diffusion
or endocytosis, was to compare the average signal inside the
cell to the background fluorescent signal inside the cell culture
chamber.
Interestingly, in the experimental conditions used, we were
not able to detect the uptake of aSyn-GFP (Figure 5A). In fact,
although these cells have a slightly higher average fluorescence
than the background (about 5%) this relation does change
significantly after a 10 h exposure to aSyn-GFP. Although
these observations seem to go against the general consensus of
the literature, several possible explanations might justify these
results: (i) the concentration of aSyn-GFP resulting from cell
release is too low; (ii) aSyn molecules that find their way inside
the cell might be rapidly degraded or re-released—in which case
experiments would need to be carried out in a shorter time
frame; (iii) molecules enter the cells in a very low number,
and consequently have no visible influence on the fluorescence
signal; (iv) GFP affects the uptake of or diffusion of aSyn,
since it is a larger protein than aSyn itself. Control experiments
in which H4 were co-cultured with H4 producing GFP seem
to support the last explanation, since no uptake of GFP was
observed (Figure 5B), however, other studies reported diffusion
of GFP into cells in similar conditions (Reyes et al., 2015).
It should be noted that in other studies using extracellular
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FIGURE 4 | Diffusion of released aSyn-GFP. (A) An intensity plot profile of fluorescent signal across the two chambers for several time points shows that after 60
min the concentration of aSyn-GFP is almost the same in both chambers. The line used for data acquisition is shown on the image on the upper right corner (white
line). (B) Fluorescence microscopy images taken 1, 20, and 60 min after opening the central channels, showing diffusion of aSyn-GFP from the left to the right
chamber. Scale bars are 100 µm, fluorescence images acquired with a 300 ms exposure.
aSyn, internalization was observed after as little as 5 min for
monomeric aSyn and 1 h for aSyn fibrils (Lee et al., 2008),
which suggests that 10 h is an appropriate time scale for such an
experiment. It is important to point out that a visible increase in
fluorescence signal was found in cells that later showed positive
PI staining, which would indicate that aSyn-GFP was able to
enter cells with a compromised membrane (Figure 6). The same
effect was verified with GFP alone. This could either indicate that
active transport is necessary to constantly remove the molecule
from inside the cell or that diffusion is less efficient across a non-
compromised membrane. In any case, additional experiments
will be required to clarify the mechanisms involved.
The use of aSyn tagged with fluorescent molecules has been
used in various studies to monitor the uptake and release of
this protein. However, these studies rely either on the use
of previously prepared conditioned medium (Lee et al., 2008,
2010), i.e., medium in which cells released aSyn, or on culturing
a populations expressing tagged aSyn together with another
population expressing another fluorescent molecule (Reyes et al.,
2015). This platform allows us to monitor the spreading of aSyn
without the need for using recombinantly produced protein.
Instead, we can directlymonitor the release of cell-produced aSyn
into the medium. The fact that we can perform all these steps
inside the device increases the speed of the assay and improves
reproducibility due to the simplification of the experimental
variables. Furthermore, by using the platform we can also keep
cells separated, thereby ensuring that any spreading happens via
mechanisms that do not require cell-cell contact.
Microglial Cells Affect the Behavior of H4
Cells
Since one of the main mechanisms through which microglia
damages neurons is by the production of ROS, we used this
microfluidic platform to monitor the effects of N9 microglia on
naïve H4 cells. N9 microglial cells share many properties with
primary microglia, namely activation by LPS and production of
interleukin (IL)-6, tumor necrosis factor (TNF), IL-1, and ROS
(Stansley et al., 2012) and are widely used in the research of
neurodegenerative diseases. There are two main ways by which
we can assess the impact of N9 on H4 cells: either by studying
indirect effects such as changes in cell viability—which can be
difficult to unequivocally relate to the presence of ROS or might
not even occur if the concentration of ROS is small—or by
directly evaluating the amount of ROS to which the cells are
subjected using fluorescent dyes.
To demonstrate how microglia-neuron interactions can be
studied in this platform, two sets of experiments were designed:
on the first, H4 cells were co-cultured with non-activated N9
cells, as a control condition; on the second, H4 cells were co-
cultured with LPS-activated N9 cells. The production of ROS and
their effect on the H4 cells was evaluated by staining these cells
with dihydroethidium (DHE), a fluorescent dye that becomes red
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FIGURE 5 | Average fluorescence intensity signal of the H4 cells
compared to the background fluorescence measured inside the cell
chamber. Fluorescence values of cells were obtained by selecting the areas
corresponding to cells in images obtained with an epifluorescence
microscope, taken with a 2 s exposure. For the assay with H4 aSyn-GFP (A),
the average signal before exposure was calculated counting 124 cells and the
average signal 10 h after exposure was calculated over 116 cells; for the assay
with H4 GFP (B) the numbers were 42 and 44, respectively. The ratio of cell
signal to background fluorescence is 1.053 before exposure to aSyn-GFP and
1.033 after exposure (A) and 1.029 before exposure to GFP and 1.027 after
exposure (B). The difference between the background before and after
exposure to aSyn-GFP or GFP can be explained by the fact that the
fluorescence images of the latter were obtained after washing the device with
PBS, which replaced the cell culture medium previously inside the cell
chambers.
and intercalates with DNA when oxidized by superoxide (Carter
et al., 1994; Bindokas et al., 1996; Owusu-Ansah et al., 2008;
Kalyanaraman et al., 2012).
Cell seeding was performed as described above and
the fluorescence signal was evaluated by selecting ROIs
corresponding to the stained nuclei of the cells in the fluorescence
microscopy images.
The results of the DHE assay showed that H4 cells co-cultured
with activated N9 cells exhibit almost twice the fluorescence
signal of cells co-cultured with non-activated N9 cells, which
suggests that they are in the presence of higher levels of ROS
(Figure 7). This difference cannot be explained merely by the
difference in the number of N9 cells, since in the assay with
non-activated cells the culture chamber contained 297 cells
whereas in the assay with LPS-activated cells, there were 451 cells,
which amounts to an increase of 52%. Furthermore, a two-tailed
Student’s t-test with unpaired data showed statistical significant
difference from the mean signal of the two populations with
p < 0.001. Although our observations produced the expected
results, i.e., that LPS-activated N9 cells increased the overall
FIGURE 6 | Fluorescence signal in dead cells. Cells with a higher
fluorescence signal from aSyn-GFP, after washing with PBS (left, white
arrows) displayed a compromised membrane after PI staining (right). This
seems to indicate that aSyn-GFP is able to penetrate and remain inside cells
with compromised membranes. Similar results were obtained for H4 wild type
cells co-cultured with H4 GFP cells. Fluorescence images were taken with 2 s
(left) and 300 ms (right).
level of ROS in H4 cells, more thorough analyses can be added
to this type of preliminary study. Since cells are confined to
microfluidic chambers, it is possible to know the exact number of
both H4 and N9 cells—and not just an estimate as in traditional
cell culture platforms. As such, it would be possible to find the
relation between the number of N9 cells and the increase in DHE
fluorescence signal. Furthermore, other ROS dyes could be used,
such as 2′,7′-dichlorfluorescein-diacetate (DCFHDA; Macedo
et al., 2014), and effects such as early apoptosis could be screened
(Vermes et al., 1995; Datta et al., 2002) to see what other effects
activated N9 have over the population. Although N9 cells pre-
activated with LPS were used in this experiment, this platform
allows the studying of the interplay of aSyn and microglia by
stimulating resting microglia with aSyn, either released by cells
or in supplemented medium. This will in turn allow replicate and
monitor the mechanisms of sustained, chronic inflammation that
occur in vivo.
DISCUSSION
In this study, a microfluidic platform was built with the aim
of establishing a tool to study contactless cell-cell interaction,
particularly in the context of synucleinopathies, such as PD. In
particular, we focused on the assessment of the value of our
platform for the study of aSyn spreading, a central problem
in PD and also in other neurodegenerative disorders such as
Alzheimer’s disease (AD), where Tau pathology has also been
show to spread in the brains of animal models (de Calignon et al.,
2012) and between co-cultured cells in vitro (Frost et al., 2009).
The platform we describe relies on two cell culture chambers
where different cell populations can be seeded independently
and the fluid flow can be easily and tightly controlled
with a set of manual switches, thus altering their chemical
microenvironment.
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FIGURE 7 | H4 cells exhibit higher ROS levels when co-cultured with
LPS-activated N9. (A) Plot of the average DHE fluorescence signal of the H4
cells. The signal of cells co-cultured with LPS-activated N9 (32 cells, 77% of
the population) is 97% higher than the one emitted from the cells co-cultured
with non-activated (vehicle) N9 (74 cells, 78% of the population); ***p < 0.001
for two-tailed Student’s t-test with unpaired data. (B) Fluorescence microscopy
image of H4 cells, co-cultured with non-activated LPS, stained with DHE.
The applicability of this platform in the study of
molecular mechanisms associated with synucleinopathies
was demonstrated by two sets of proof-of-concept experiments
addressing two major hallmarks of the disease: the spreading
of aSyn and cell-cell communication between different cell
types (neurons and glia). In particular, we focused on the
interplay between neuronal and microglial cells, to study
microglia-mediated neuroinflammatory responses.
In the first set of experiments, we showed that it was possible
to obtain a very fine control over the cells’ microenvironment
by permeabilizing one cell population and leaving the other
untouched. This approach released fluorescently-tagged
molecules into the medium, which then diffused to the adjoining
chamber. The set of integrated valves enabled the isolation of
each chamber, thereby preventing the chemicals of interest
from diffusing outside the chambers and being diluted. Cells
survived 10 h without medium change and time-lapse imaging
revealed cell motility and proliferation. Although we could not
detect the uptake of aSyn-GFP, this device can be used to study
transmission of proteins and other communication between
cells exclusively through soluble molecules. This approach has
the added advantage of releasing aSyn forms that naturally
occur in cells, circumventing the need for adding purified
recombinant proteins that are aggregated outside of the cellular
environment and, therefore, less physiologically relevant. In
the case of cells with high motility, extra steps can be taken to
ensure that populations never come in direct contact with each
other, namely by not coating the central channels with FN or
even coating them with proteins that decrease cell adhesion such
as bovine serum albumin (Klebe et al., 1981). Although, in this
experimental protocol cells were lysed to release their contents,
other approaches can be studied using this platform, such as
tracking exocytosis of tagged aSyn aggregates using stressed cells
or cells transfected with mutant aSyn.
In the second set of experiments, our goal was to observe,
in real time, how cells with microglial phenotypes affected
H4 cells. This was done by monitoring the diffusion of ROS
produced by LPS-activated N9 cells in one chamber to the other
chamber containing H4 cells via the positive staining of the H4
cells with DHE, an ROS dye. Given the control in fluid flow
provided by this platform, it can also be used to expose N9
populations with different chemicals and observe their effect
side-by-side—e.g., assess the kinetics of activation with different
activators—and to replicate in vitro, with greater accuracy,
events that occur during neuroinflammation. This second set of
experiments aimed at exploring this device’s capabilities to deliver
venues of exploring ROS-based phenomena, and subsequent
experiments in which exposure times and cell densities could
provide interesting new data. Furthermore, additional techniques
such as immunocytochemistry can also be used in this platform,
which can be used to further study cell response to stimulus—
e.g., the activation level of microglia when exposed to different
concentrations of aSyn by using anti-Iba1 markers (Ito et al.,
1998).
This platform also offers the possibility of studying
chemotaxis. For example, it was observed that when cultured on
their own, with no cells in the other chamber, non-activated N9
cells were highly motile but did not have a clear direction and
did not cross to the other chamber (Supplementary Video 1).
Future experiments can be designed to assess whether chemicals
produced by a given cell population, such as aggregated aSyn
(Wang et al., 2015), attract microglia: the existence of chemotaxis
can be verified by comparing the number of cells that cross to
the other chamber and comparing it to a control.
Although, co-culture platforms with pneumatic valves already
exist, it is the number and position of the valves that makes
this device highly versatile, since it allows not only bi-directional
communication by diffusion, but also to establish one-sided
communication by slowly perfusing cell culture medium from
one chamber to the other. Although, the cell lines used in
this work were useful for the proof of concept, and showed
how in vivo events relevant to PD can be replicated on this
platform, future studies of the molecular mechanisms of this
disease should also involve primary cell cultures, but will involve
future layers of optimization that go beyond the scope of the
present study. In conclusion, our study established a novel
microfluidic device enabling the study of cell-cell communication
in tightly controlled conditions that will prove useful in many
biomedically-relevant settings.
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